Search bioRxiv⌕ Search

Biology subjects

Jarhult, J. D.

Publications and source records attributed to Jarhult, J. D..

4 recordsLinked to original sources

Polymicrobial catheter biofilms sustain susceptible Enterococcus faecalis and Escherichia coli during β-lactam treatment

Broad-spectrum {beta}-lactam exposure can select for Enterococcus-dominated urinary communities in catheterized intensive-care patients, even when co-colonizing Escherichia coli remains susceptible. We investigated paired E. faecalis and E. coli isolates recovered before and after piperacillin-tazobactam (TZP) treatment using a catheter biofilm model and showed that their survival depends on mutualism and biofilm-dependent persistence. Without antibiotics, E. faecalis reduced E. coli biofilm formation yet promoted pre-attachment co-aggregation and reorganized mixed-biofilm architecture on the catheter. Despite TZP susceptibility and the absence of resistance determinants, catheter-associated biofilms and biofilm-dispersed cells survived concentrations 250- to 1000-fold above their MICs, whereas planktonic cells were eliminated. Survivors retained susceptibility but showed delayed regrowth, consistent with a transient persister-like state. In the post-treatment pair, each species sustained the other during recovery, coinciding with a nonsynonymous substitution in the enterococcal surface adhesin Esp. These findings show that antagonistic and cooperative interactions can coexist within catheter biofilms and enable susceptible polymicrobial communities to withstand {beta}-lactam treatment without {beta}-lactam resistance.

microbiology↗

Heterogeneity and Metabolic Diversity among Enterococcus Species during Long-term Colonization

Urinary tract infections (UTIs), traditionally dominated by Gram-negative pathogens, are increasingly complicated by antimicrobial-resistant Enterococcus spp. in hospital settings. This study screened urine samples from 210 ICU patients at Uppsala University Hospital (June 2020 - September 2021), identifying 39 unique PhenePlate-RF types across E. faecium, E. faecalis, and E. durans. E. faecium isolates showed considerable genetic diversity, primarily within clonal complex 17 (CC17), known for its virulence and antibiotic resistance. We identified multiple lineages and sequence types (STs), such as in patient HWP143, who had isolates from both ST80 and ST22 (an ancestral CC17 lineage). Notably, metabolic adaptations, such as increased L-arabinose metabolism, and shifts in antibiotic resistance were observed. Variations and similarities in plasmid content between individual linages suggest horizontal gene transfer. E. faecalis isolates exhibited less genetic diversity but significant metabolic variability across patients and mixed infections, as seen in patient HWP051, colonized by both ST16 (CC58) and ST287. E. durans, though less common, shared important metabolic traits with E. faecium and displayed polyclonal characteristics, highlighting its potential role in UTIs and the complexity of enterococcal infections. E. durans was sometimes misidentified, underscoring the need for accurate identification methods. This research underscores the importance of understanding genetic and metabolic diversity, plasmid variations, and horizontal gene transfer in Enterococcus spp., which influence antibiotic resistance, virulence, and ultimately, treatment outcomes. IMPORTANCE STATEMENTOur study uncovers novel insights into the genetic and metabolic diversity of Enterococcus species within individual patients, focusing on E. faecium, E. faecalis, and E. durans. Unlike prior studies, which often focused on single lineages, we reveal multiple clones and lineages across individual patients, including clones from clonal complex 17 and the emerging sequence type (ST) 192, highlighting notable metabolic adaptations and shifts in antibiotic resistance. The detection of mixed colonization with varied ST-types, and E. durans misidentification by MALDI-TOF, later corrected by sequencing, further emphasizes the challenges in Enterococcus species identification. For the first time, we demonstrate likely horizontal gene transfer among E. faecium, E. faecalis, and E. durans within the same patient, underscoring the dynamic nature of these infections. Our findings have significant implications for understanding the complexity of Enterococcus infections, stressing the need to consider genetic and metabolic diversity to improve disease management and treatment outcomes.

microbiology↗

Identification of unique and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries

In vitro screening of large compounds libraries with automated high-throughput screening is expensive, time consuming and requires dedicated infrastructures. Conversely, the selection of DNA-encoded chemical libraries (DECL) can be rapidly performed with routine equipment available in most laboratories. In this study we identified novel inhibitors of SARS-CoV-2 main protease (Mpro) through the affinity-based selection of the DELopen library (open access for academics), containing 4.2 billion compounds. The identified inhibitors were peptide-like compounds containing an N-terminal electrophilic group able to form a covalent bond with the nucleophilic Cys145 of Mpro, as confirmed by x-ray crystallography. This DECL selection campaign enabled the discovery of the unoptimized compound SLL11 displaying an IC50 of 30 nM, proving that the rapid exploration of large chemical spaces enabled by DECL technology, allows for the direct identification of potent inhibitors avoiding several rounds of iterative medicinal chemistry. Compound MP1, a close analogue of SLL11, showed antiviral activity against SARS-CoV-2 in the low micromolar range when tested in Caco-2 and Calu-3 (EC50 = 2.3 {micro}M) cell lines. As peptide-like compounds can suffer from low cell permeability and metabolic stability, the cyclization of the compounds as well as the substitution of selected residues with D-enantiomers will be explored in the future to improve the antiviral activity of these novel compounds.

microbiology↗

Revealing interspecies transmission barriers of avian influenza A viruses

Influenza A virus (IAV) pandemics result from interspecies transmission events within the avian reservoir and further to mammals including humans. Investigating molecular virus-host interactions dictating this process and the adaptations to the new hosts that follow is vital to understand zoonotic IAV spread. Receptor incompatibility has been suggested to limit zoonotic IAV transmission from the wild bird reservoir. Other barriers to interspecies transmission, particularly within the avian system, largely remain elusive. Through assessment of infection dynamics of mallard origin IAV in two different avian hosts, coupled with studies of receptor expression and host response we aimed to reveal the host-pathogen interactions in a cross-species transmission event. We found that shedding patterns and innate immune responses were highly dependent on viral genotypes, host species and inoculation routes, but less dependent on receptor expression. Further, in contrary to the prevailing dogma we demonstrate that birds can produce a wide range of different sialylated structures also found in mammals, e.g. extended N- and O-linked Neu5Ac2,6 terminated glycans. Overall, receptor incompatibility is not the sole transmission barrier for IAV between birds and to humans, but other host-pathogen factors deserve dedicated studies to achieve proper pandemic preparedness.

microbiology↗